does pfizer have a glp-1 drug moves forward with weight-loss pill—a needle-free alternative to Wegovy and Ozempic Understanding GLP-1 Drugs: Cost, Safety,
Description
Although the mechanisms leading to a blood pressure decrease during the treatment with GLP-1 agonists have not been fully elucidated it could be the result of an increased sodium and water excretion and/or inhibition of the RAAS activity 14

But big picture, biologically, humans evolved in scarcity

The Current State of GLP-1 Drugs 2023 research from IQVIA has shown that demand for GLP-1 drugs has accelerated since early 2020, corresponding to the launches of Ozempic, Wegovy and Mounjaro variations

Over the next few years, we will need to monitor how the healthcare system will tackle these issues without the benefit of commercial managed care oversight.
Progress & body metric tools to help you measure your progress over time
